Evidence map›Paper›PMID 33482915›Full record

ArticleCell & bioscience2021

SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study.

Jingshu Liu, Jiangfeng Qiu, Zhiqi Zhang, Lei Zhou, Yunzhe Li, Dongyan Ding, Yang Zhang, Dongling Zou, Dong Wang, Qi Zhou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERα and FOXA.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Jingshu LiuCollege of Bioengineering, Chongqing University, 400044, Chongqing, People's Republic of China.
Jiangfeng QiuDepartment of Gastrointestinal Surgery, Renji Hospital Shanghai Jiao Tong University School of Medicine, 200127, Shanghai, People's Republic of China.
Zhiqi ZhangDepartment of General Surgery, School of Medicine, Shanghai Fourth People's Hospital Affiliated to Tongji University, 200081, Shanghai, People's Republic of China.
Lei ZhouSingapore Eye Research Institute, The academia, 20 College Road, Discovery Tower Level 6, 169856, Singapore, Singapore.
Yunzhe LiCollege of Bioengineering, Chongqing University, 400044, Chongqing, People's Republic of China.
Dongyan DingCollege of Bioengineering, Chongqing University, 400044, Chongqing, People's Republic of China.
Yang ZhangLaboratory Department, Chongqing University Cancer Hospital, 400030, Chongqing, People's Republic of China.
Dongling ZouDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital, 400030, Chongqing, People's Republic of China.
Dong WangDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital, 400030, Chongqing, People's Republic of China.
Qi ZhouCollege of Bioengineering, Chongqing University, 400044, Chongqing, People's Republic of China. cqzl_zq@163.com.ORCID http://orcid.org/0000-0002-0441-584X
Tingyuan LangCollege of Bioengineering, Chongqing University, 400044, Chongqing, People's Republic of China. michaellang2009@163.com.
Chongqing University · CNNational University of Singapore · SGShanghai Jiao Tong University · CNTongji University · CN

Funding

Chongqing Science and Technology Commission cstc2019jscx-msxmX0106Chongqing Science and Technology Commission cstc2019jscx-msxmX0174National Key Research Program "Precision Medical Research" 2017YFC0909900National Natural Science Foundation of China 81701183
6 · The paper itself

Abstract

backgroundCancer stem cells (CSCs) are the root of human cancer development and the major cause of treatment failure. Aberrant elevation of SOX4, a member of SOX (SRY-related HMG-box) family transcription factors, has been identified in many types of human cancer and promotes cancer development. However, the role of SOX4 in CSCs, especially at a proteome-wide level, has remained elusive. The aim of this study is to investigate the effect of SOX4 on the stemness of CSCs and reveal the underlying mechanisms by identification of SOX4-induced proteome changes through proteomics study.

resultsOverexpression of SOX4 promotes sphere formation and self-renewal of colorectal cancer cells in vitro and in vivo and elevates the expression levels of CSCs markers. Through iTRAQ-based quantitative proteomics analysis, 215 differentially expressed proteins (128 upregulated, 87 downregulated) in SOX4-overexpressing HCT-116 spheres were identified. The bioinformatic analysis highlighted the importance of HDAC1 as the fundamental roles of its impacted pathways in stem cell maintenance, including Wnt, Notch, cell cycle, and transcriptional misregulation in cancer. The mechanistic study showed that SOX4 directly binds to the promoter of HDAC1, promotes HDAC1 transcription, thereby supporting the stemness of colorectal cancer cells. HDAC1 hallmarks colorectal cancer stem cells and depletion of HDAC1 abolished the stimulatory effect of SOX4. Furthermore, SOX4-HDAC1 axis is conserved in multiple types of cancer.

conclusionsThe results of this study reveal SOX4-induced proteome changes in HCT-116 spheres and demonstrates that transcriptional activation of HDAC1 is the primary mechanism underlying SOX4 maintaining CSCs. This finding suggests that HDAC1 is a potential drug target for eradicating SOX4-driven human CSCs.

Indexed as

Cancer stem cellsComparative proteomicsHDAC1Precision medicineSOX4Transcriptional activation

Identifiers

PMID33482915
PMCPMC7821488
OpenAlexW3123991576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.